Lorcaserin for weight loss: insights into US Food and Drug Administration approval

scientific article published in January 2013

Lorcaserin for weight loss: insights into US Food and Drug Administration approval is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JAND.2012.08.028
P698PubMed publication ID23260720
P5875ResearchGate publication ID233973989

P50authorLarry E. MillerQ38601507
P433issue1
P304page(s)25-30
P577publication date2013-01-01
P1433published inJournal of the Academy of Nutrition and DieteticsQ6296079
P1476titleLorcaserin for weight loss: insights into US Food and Drug Administration approval
P478volume113

Reverse relations

cites work (P2860)
Q38770244Endogenous 5-HT2C Receptors Phosphorylate the cAMP Response Element Binding Protein via Protein Kinase C-Promoted Activation of Extracellular-Regulated Kinases-1/2 in Hypothalamic mHypoA-2/10 Cells
Q92311971Intraperitoneal administration of follistatin promotes adipocyte browning in high-fat diet-induced obese mice
Q36206061Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review
Q38308961Safety assessment of FDA-approved (orlistat and lorcaserin) anti-obesity medications
Q41888121The next generation of obesity treatments: beyond suppressing appetite

Search more.